Cell Cycle/Checkpoint


The cell cycle is consisted of 4 main phases: Gap 1 (G1), DNA replication (S), Gap 2 (G2), and mitosis (M). There are “checkpoints” mechanism regulates the transition between these phases, at the G1/S boundary, in the S-phase and during G2/M phases. Cell can only pass through these checkpoints when signaling factors are activated and free of DNA damage. Important proteins that control cell cycle events and checkpoints are cullins, cyclins, cyclin-dependent kinases (Cdks), p53 and their inhibitors etc. Cdks family (Cdk2, Cdk3, Cdk4 and Cdk6) are Ser/Thr kinases that regulate cell cycle progression in association with cyclin binding partners (cyclin D, cyclin E and cyclin A) during all four phases. p53 halts the cell cycle if the DNA is damaged and allowing time for DNA repair to progress; it can also initiate apoptosis if DNA damage is too severe to be repaired.
-
BA2835 NitrochinSummary: Nitrochin (4-NQO) is a chemical carcinogen. -
BA2841 L67Summary: L67 (DNALigaseInhibitor) is a competitive DNA ligase inhibitor that potently inhibits DNA ligases I and III (both 10 μM). -
BA2862 ForodesineSummary: Forodesine (BCX-1777) is a potent, orally active purine nucleoside phosphorylase inhibitor with values ranging from 0.48 to 1.57 nM in humans, mice, rats, monkeys and dogs. -
BA2886 MBM-55Summary: MBM-55 is an effective inhibitor. -
BA2903 SCR130Summary: SCR130 is an SCR7-based inhibitor of DNA non-homologous end joining. -
BA3362 RK-9123016Summary: RK-9123016 is a potent inhibitor. -
BA3520 PlevitrexedSummary: Plevitrexed (ZD9331; BGC9331) is an orally effective inhibitor of thymidylate synthase. -
BA5870 RBN013209Summary: RBN013209 is a potent inhibitor. -
BA5944 VudalimabSummary: Vudalimab is a potent and dual inhibitor, a fully humanized bispecific monoclonal antibody. -
BA5947 TuvonralimabSummary: Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blocker.

